[HTML] nature.com

[HTML][HTML] Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

L Salz, A Seitz, D Schäfer, J Franzen, T Holzer… - Leukemia, 2023 - nature.com
Chimeric antigen receptor (CAR) T cells provide new perspectives for treatment of
hematological malignancies. Manufacturing of these cellular products includes culture …
被引用次数：7 相关文章

Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

L Salz, A Seitz, D Schäfer, J Franzen, T Holzer… - …, 2023 - upcommons.upc.edu
Chimeric antigen receptor (CAR) T cells provide new perspectives for treatment of
hematological malignancies. Manufacturing of these cellular products includes culture …

Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

L Salz, A Seitz, D Schäfer, J Franzen, T Holzer… - Leukemia, 2023 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Chimeric antigen receptor (CAR) T cells
provide new perspectives for treatment of hematological malignancies. Manufacturing of …
[HTML] nih.gov

[HTML][HTML] Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

L Salz, A Seitz, D Schäfer, J Franzen, T Holzer… - Leukemia, 2023 - ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T cells provide new perspectives for treatment of
hematological malignancies. Manufacturing of these cellular products includes culture …

Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome.

L Salz, A Seitz, D Schäfer, J Franzen, T Holzer… - Leukemia, 2023 - europepmc.org
Chimeric antigen receptor (CAR) T cells provide new perspectives for treatment of
hematological malignancies. Manufacturing of these cellular products includes culture …
[PDF] rwth-aachen.de

[PDF][PDF] Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

L Salz, A Seitz, D Schäfer, J Franzen, T Holzer… - 2023 - publications.rwth-aachen.de
Cellular immunotherapy using autologous, genetically modified T cells has delivered
remarkable initial response rates in various hematological malignancies, including acute …

Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

L Salz - 2023 - ddd.uab.cat
Chimeric antigen receptor (CAR) T cells provide new perspectives for treatment of
hematological malignancies. Manufacturing of these cellular products includes culture …
[PDF] researchgate.net

[PDF][PDF] Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

L Salz, A Seitz, D Schäfer, J Franzen, T Holzer… - 2023 - researchgate.net
Cellular immunotherapy using autologous, genetically modified T cells has delivered
remarkable initial response rates in various hematological malignancies, including acute …

Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

L Salz, A Seitz, D Schäfer, J Franzen, T Holzer… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T cells provide new perspectives for treatment of
hematological malignancies. Manufacturing of these cellular products includes culture …

Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome.

L Salz, A Seitz, D Schäfer, J Franzen, T Holzer… - Leukemia, 2023 - europepmc.org
Chimeric antigen receptor (CAR) T cells provide new perspectives for treatment of
hematological malignancies. Manufacturing of these cellular products includes culture …